News | October 09, 2022
Pfizer acquires Global Blood Therapeutics
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Lenalidomide is used to treat various types of cancers.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Thalassemia and Sickle Cell Society (TSCS) always stands forefront in providing blood transfusion free of cost for Thalassemia Blood disorders patients
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Subscribe To Our Newsletter & Stay Updated
